P.F.C. SIGMA RPF 95-0026Recalls & reported problems
Depuy (Ireland) · P.F.C. SIGMA FEMORAL RPF CEMENTED SIZE 5 RIGHT · Class 3 · Implant
All models of P.F.C. SIGMA RPF (12)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10603295224129), received between Feb 19, 2018 and Feb 15, 2021 — classified as 3 injuries.
The most frequently reported specific device problem is “Loss of or Failure to Bond” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Loss of or Failure to Bond2
- Loosening of Implant Not Related to Bone-Ingrowth1
Patient problems
- Pain3
- No Code Available1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryFeb 15, 2021Loss of or Failure to Bond; Loss of or Failure to Bond
THE PATIENT WAS REVISED TO ADDRESS PAIN AND LOOSENING OF THE UNKNOWN COMPONENT AT THE BONE TO CEMENT AND CEMENT TO IMPLANT INTERFACES. THERE WAS LOOSENING AND SIGNIFICANT DELAMINATION OF THE PATELLA AND SOME ON THE TIBIAL INSERT. THE PATELLA WASN'T LOOSE, BUT THERE WAS LOOSENING ON THE TIBIAL TRAY AND FEMORAL COMPONENT. DEPUY CEMENT WAS USED. NO ADDITIONAL INFORMATION. DOI: (B)(6) 2007, DOR: (B)(6) 2021, RIGHT KNEE.
Patient problems: Pain
MAUDE report 11327627 ↗InjurySep 25, 2019Loosening of Implant Not Related to Bone-Ingrowth; Loosening of Implant Not Related to Bone-Ingrowth
PRIMARY IMPLANT DATE: (B)(6) 2007. REASON FOR REVISION: PAIN, LOOSENING AND INSTABILITY OF FEMORAL COMPONENT. ACTION TAKEN: REMOVAL OF PRIMARY IMPLANT. INSERTION OF NEW REVISION IMPLANTS.
Patient problems: No Code Available; Pain
MAUDE report 9120340 ↗InjuryFeb 19, 2018Loss of or Failure to Bond; Loss of or Failure to Bond
REVISION RIGHT TKR DR (B)(6) HOSPITAL (B)(6) 2018 PRIMARY (B)(6) 2015 FOR RIGHT TKR THIS IS PATIENT'S FIRST REVISION: PRESENTED TO SURGEON WITH PAIN?INFECTION? ASEPTIC LOOSENING. ALL PRIMARY IMPLANTS AND BONE CEMENT REVISED AND PROCEED TO REVISION RIGHT TKR. MALE PATIENT (B)(6) YEARS OLD.
Patient problems: Pain
MAUDE report 7279728 ↗
Other Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing devices
- ATTUNE 1506-10-005Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing442 reports
- ATTUNE 1506-10-004Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing442 reports
- ATTUNE 1518-20-038Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing3 deaths393 reports
- LCS SIGMA 1294-33-130Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing1 recall310 reports
- ATTUNE 1518-20-035Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing342 reports
- P.F.C. SIGMA 96-0102Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing1 death319 reports
- ATTUNE 1518-20-041Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing308 reports
- ATTUNE 1506-10-007Depuy (Ireland) · Prosthesis, knee, patellofemorotibial, semi-constrained, metal/polymer, mobile bearing284 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page